Cargando…
Treatment Combinations for Alzheimer’s Disease: Current and Future Pharmacotherapy Options
Although Alzheimer’s disease (AD) is the world’s leading cause of dementia and the population of patients with AD continues to grow, no new therapies have been approved in more than a decade. Many clinical trials of single-agent therapies have failed to affect disease progression or symptoms compare...
Autores principales: | Cummings, Jeffrey L., Tong, Gary, Ballard, Clive |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398562/ https://www.ncbi.nlm.nih.gov/pubmed/30689575 http://dx.doi.org/10.3233/JAD-180766 |
Ejemplares similares
-
Pain in the neurodegenerating brain: insights into pharmacotherapy for Alzheimer disease and Parkinson disease
por: Lawn, Timothy, et al.
Publicado: (2021) -
Overactive bladder syndrome pharmacotherapy: future treatment options
por: Wróbel, Andrzej
Publicado: (2015) -
Current Pharmacotherapy and Multi-Target Approaches for Alzheimer’s Disease
por: Cheong, Siew Lee, et al.
Publicado: (2022) -
Combination pharmacotherapy in Alzheimer's disease
por: Mintzer, Jacobo, et al.
Publicado: (2003) -
Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options
por: Garakani, Amir, et al.
Publicado: (2020)